Helmut Klocker
Helmut Klocker
Assoc.Prof. for Medical Biochemistry, Medical University Innsbruck
Potvrđena adresa e-pošte na - Početna stranica
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor
Z Culig, A Hobisch, MV Cronauer, C Radmayr, J Trapman, A Hittmair, ...
Cancer research 54 (20), 5474-5478, 1994
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.
Z Culig, A Hobisch, MV Cronauer, AC Cato, A Hittmair, C Radmayr, ...
Molecular endocrinology 7 (12), 1541-1550, 1993
Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor
A Hobisch, IE Eder, T Putz, W Horninger, G Bartsch, H Klocker, Z Culig
Cancer research 58 (20), 4640-4645, 1998
Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system
Z Culig, J Hoffmann, M Erdel, IE Eder, A Hobisch, A Hittmair, G Bartsch, ...
British journal of cancer 81 (2), 242-251, 1999
Nanoparticle-based bio-barcode assay redefines “undetectable” PSA and biochemical recurrence after radical prostatectomy
CS Thaxton, R Elghanian, AD Thomas, SI Stoeva, JS Lee, ND Smith, ...
Proceedings of the National Academy of Sciences 106 (44), 18437-18442, 2009
Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria
G Bartsch, W Horninger, H Klocker, A Reissigl, W Oberaigner, ...
Urology 58 (3), 417-424, 2001
Regulation of prostatic growth and function by peptide growth factors
Z Culig, A Hobisch, MV Cronauer, C Radmayr, A Hittmair, J Zhang, ...
The Prostate 28 (6), 392-405, 1996
Distant metastases from prostatic carcinoma express androgen receptor protein
A Hobisch, Z Culig, C Radmayr, G Bartsch, H Klocker, A Hittmair
Cancer research 55 (14), 3068-3072, 1995
Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells
The Journal of urology 161 (3), 777-782, 1999
Prostaglandin E2 and tumor necrosis factor α cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production
C Rieser, G Böck, H Klocker, G Bartsch, M Thurnher
The Journal of experimental medicine 186 (9), 1603-1608, 1997
Rapid signalling by androgen receptor in prostate cancer cells
H Peterziel, S Mink, A Schonert, M Becker, H Klocker, ACB Cato
Oncogene 18 (46), 6322-6329, 1999
Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection
FH Jansen, RHN van Schaik, J Kurstjens, W Horninger, H Klocker, ...
European urology 57 (6), 921-927, 2010
Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients
H Fiegl, S Millinger, E Mueller-Holzner, C Marth, C Ensinger, A Berger, ...
Cancer research 65 (4), 1141-1145, 2005
Dihydrotestosterone and the concept of 5α–reductase inhibition in human benign prostatic hyperplasia
G Bartsch, RS Rittmaster, H Klocker
European urology 37 (4), 367-380, 2000
Androgen receptors in prostate cancer.
Z Culig, H Klocker, G Bartsch, A Hobisch
Endocrine-related cancer 9 (3), 155-170, 2002
Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205
M Puhr, J Hoefer, G Schäfer, HHH Erb, SJ Oh, H Klocker, I Heidegger, ...
The American journal of pathology 181 (6), 2188-2201, 2012
Serum pro prostate specific antigen improves cancer detection compared to free and complexed prostate specific antigen in men with prostate specific antigen 2 to 4 ng/ml
WJ Catalona, G Bartsch, HG Rittenhouse, CL Evans, HJ Linton, ...
The Journal of urology 170 (6), 2181-2185, 2003
Immunohistochemical localization of interleukin‐6 and its receptor in benign, premalignant and malignant prostate tissue
A Hobisch, H Rogatsch, A Hittmair, D Fuchs, G Bartsch Jr, H Klocker, ...
The Journal of pathology 191 (3), 239-244, 2000
Serum pro-prostate specific antigen preferentially detects aggressive prostate cancers in men with 2 to 4 ng/ml prostate specific antigen
WJ Catalona, G Bartsch, HG Rittenhouse, CL Evans, HJ Linton, ...
The Journal of urology 171 (6 Part 1), 2239-2244, 2004
Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides
IE Eder, Z Culig, R Ramoner, M Thurnher, T Putz, C Nessler-Menardi, ...
Cancer Gene Therapy 7 (7), 997-1007, 2000
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20